Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Business News
The Federal Trade Commission voted to dismiss a lawsuit filed in the last days of the Biden administration that accused PepsiCo of offering sweetheart...
Business News
OpenAI on Wednesday announced that it now has 3 million paying business users, up from the 2 million it reported in February. The San...
Stock News
The bullish signals stacked up in April and May, but most long-term breadth indicators are still bearish. SPY and QQQ showed signs of capitulation...
Investing News
After spending most of 2025’s first quarter consolidating at the US$63 per pound level, spot U3O8 prices have been on an upswing, adding 13.62...